Drug Discovery & Development
News on drug screening, clinical trials, companion diagnostics, immunotherapy, & personalized therapies in genetics, genomics, and molecular diagnostics.
Its developers have founded a company, Atavistik Bio, to commercialize the method, which has applications in drug development and basic research.
Protai Expands Seed Round to $20M
The company added $12 million to its initial $8 million in funding as it looks to build out its pipeline and platform for proteomic-based cancer drug discovery.
Metabolomics Research Services Firm Panome Bio Raises $6M
Panome Bio is advancing a biomarker- and drug-discovery platform developed by its cofounder at Washington University.
Sermonix Pharma Using Guardant Health CDx to Screen Breast Cancer Patients for Lasofoxifene Trial
The ELAINE-3 study, a Phase III trial, will use the Guardant360 CDx liquid biopsy test to screen patients for ESR1 mutations.
Caris to Provide Biomarker Discovery, Molecular Testing for Incyte Oncology Drug Development
Pharma firm Incyte is working with Caris on two drug programs initially, with the option to expand to four in total and the possibility of CDx partnerships.